Hemopathy
Conditions
Interventions
Experimental group:After the placement of the MC, observe the incidence of catheter-related complications within 30 days post catheterization in patients.
Control group:After the placement of the PICC, observe the incidence of catheter-related complications within 30 days post-catheterization in the patient.
Sponsors
Peking University People's Hospital
Eligibility
Sex/Gender
All
Age
16 Years to No maximum
Inclusion criteria
Inclusion criteria: a. Patients diagnosed with acute leukemia according to the WHO (2016) classification standards for hematopoietic and lymphoid tissue tumors; b. Age >= 16 years, with no restrictions on gender or ethnicity; c. Patients requiring intravenous infusion of chemotherapy drugs; d. Expected intravenous infusion duration >= 7 days; e. No history of thrombosis, vascular injury, infection, or other conditions; f. Consent to participate in clinical research and sign an informed consent form.
Exclusion criteria
Exclusion criteria: a. There is pain at the puncture site, and the skin has damage or open wounds; b. There is vascular damage at the puncture site, such as bruising, exudation, phlebitis, sclerosis, cord-like formations, or congestion; c. There is edema in the punctured limb, and infection has occurred; d. Patients with a history of thrombosis, hypercoagulable states, reduced limb blood flow, or end-stage renal disease requiring venous protection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Catheter obstruction;Catheter related thrombosis;Vessel Catheter Associated Infection;Evaluation of Patient Comfort Status; | — |
Countries
China
Contacts
Public ContactWang Yan
Peking University People's Hospital
Outcome results
None listed